![](/img/cover-not-exists.png)
A phase-I trial of a novel autologous oxidized whole-tumor antigen vaccine therapy for recurrent ovarian cancer
Tanyi, J., Kandalaft, L., Chiang, C., Mantia-Smaldone, G., Zsiros, E., Powell, D., Coukos, G.Volume:
130
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2013.04.084
Date:
July, 2013
File:
PDF, 72 KB
english, 2013